RJFSA
SGNT

Raymond James Financial Services Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Raymond James Financial Services Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-66,411
Closed -$995K – 2440
2016
Q2 		$995K Buy
66,411
+28,207
+74% +$362K 0.01% 1042
2016
Q1 		$465K Buy
38,204
+906
+2% +$12.7K 0.01% 1291
2015
Q4 		$593K Buy
37,298
+8,120
+28% +$128K 0.01% 1135
2015
Q3 		$447K Buy
+29,178
New +$631K 0.01% 1102

Raymond James Financial Services Advisors's SGNT Position: Q3 2016 in Review

Raymond James Financial Services Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 66,411 shares — an estimated $995K sold.

Raymond James Financial Services Advisors first reported a position in SGNT in Q3 2015 and held it in 4 quarters. The position peaked at $995K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Raymond James Financial Services Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 66,411 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $995K.
  • Raymond James Financial Services Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2015 and held it in 4 quarters.
  • Raymond James Financial Services Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $995K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.